These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31556310)

  • 1. Investigations beyond standard operating procedure on internal standard response.
    Buonarati MH; Schoener D
    Bioanalysis; 2019 Sep; 11(18):1669-1678. PubMed ID: 31556310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in internal standard response: some thoughts and real-life cases.
    Blaye OL
    Bioanalysis; 2019 Sep; 11(18):1715-1725. PubMed ID: 31556317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic internal standard variability and issue resolution: two case studies.
    Verhaeghe T
    Bioanalysis; 2019 Sep; 11(18):1685-1692. PubMed ID: 31596112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learning how to interpret 'dangerous' internal standard behaviors.
    J Woolf E
    Bioanalysis; 2019 Sep; 11(18):1679-1684. PubMed ID: 31556306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very complex internal standard response variation in LC-MS/MS bioanalysis: root cause analysis and impact assessment.
    van de Merbel NC; Koster RA; Ohnmacht C
    Bioanalysis; 2019 Sep; 11(18):1693-1700. PubMed ID: 31566440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internal standards in regulated bioanalysis: putting in place a decision-making process during method development.
    Wright MJ; Wheller R; Wallace G; Green R
    Bioanalysis; 2019 Sep; 11(18):1701-1713. PubMed ID: 31646889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in internal standard: an inspector's perspective.
    Vinter S
    Bioanalysis; 2019 Sep; 11(18):1649-1651. PubMed ID: 31617397
    [No Abstract]   [Full Text] [Related]  

  • 8. Japanese bioanalytical method validation guideline: the world's first regulatory guideline dedicated to ligand-binding assays.
    Imazato-Hirano M; Taniguchi Y; Kakehi M; Kuze Y; Nakamura T; Minamide Y; Miya K; Hosogi J; Katashima M; Maekawa K; Okuda H; Niimi S; Kawasaki N; Ishii-Watabe A; Katori N
    Bioanalysis; 2015; 7(9):1151-6. PubMed ID: 26039811
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis.
    Lowes S; Jersey J; Shoup R; Garofolo F; Savoie N; Mortz E; Needham S; Caturla MC; Steffen R; Sheldon C; Hayes R; Samuels T; Di Donato L; Kamerud J; Michael S; Lin ZJ; Hillier J; Moussallie M; de Souza Teixeira L; Rocci M; Buonarati M; Truog J; Hussain S; Lundberg R; Breau A; Zhang T; Jonker J; Berger N; Gagnon-Carignan S; Nehls C; Nicholson R; Hilhorst M; Karnik S; de Boer T; Houghton R; Smith K; Cojocaru L; Allen M; Harter T; Fatmi S; Sayyarpour F; Vija J; Malone M; Heller D
    Bioanalysis; 2011 Jun; 3(12):1323-32. PubMed ID: 21679026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method transfer between bioanalytical laboratories.
    Hill HM; Smith G
    Bioanalysis; 2015; 7(7):783-7. PubMed ID: 25932511
    [No Abstract]   [Full Text] [Related]  

  • 11. Direct quantification in bioanalytical LC-MS/MS using internal calibration via analyte/stable isotope ratio.
    Nilsson LB; Eklund G
    J Pharm Biomed Anal; 2007 Feb; 43(3):1094-9. PubMed ID: 17084056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural elements involved in maintaining bioanalytical data integrity for good laboratory practices studies and regulated clinical studies.
    James CA; Hill HM
    AAPS J; 2007 Apr; 9(2):E123-7. PubMed ID: 17614354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilizing enzymatic digestion procedures in the bioanalytical laboratory.
    Szapacs M; Mencken T; Williams J; Li Y
    Bioanalysis; 2016; 8(1):29-36. PubMed ID: 26648043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quest for assay robustness across the life cycle of a bioanalytical method.
    White S; Dunn J; Summerfield S
    Bioanalysis; 2015; 7(7):815-24. PubMed ID: 25932516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal standard response variations during incurred sample analysis by LC-MS/MS: Case by case trouble-shooting.
    Tan A; Hussain S; Musuku A; Massé R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3201-9. PubMed ID: 19733134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples.
    Jemal M; Ouyang Z; Powell ML
    Rapid Commun Mass Spectrom; 2002; 16(16):1538-47. PubMed ID: 12203245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations and best practices for reference standards and reagents used in bioanalytical method validation.
    Bower JF; McClung JB; Watson C; Osumi T; Pastre K
    AAPS J; 2014 Mar; 16(2):352-6. PubMed ID: 24500277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilizing Internal Standard Responses to Assess Risk on Reporting Bioanalytical Results from Hemolyzed Samples.
    Fung EN; Aubry AF; Allentoff A; Ji QC
    AAPS J; 2015 Sep; 17(5):1168-76. PubMed ID: 25975617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust, fit-for-purpose method transfer: why we should apply equivalence testing.
    Wieling J
    Bioanalysis; 2015; 7(7):807-14. PubMed ID: 25932515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.